Last reviewed · How we verify
SFP
SFP is an iron-based intravenous therapy that replenishes iron stores and stimulates erythropoiesis in patients with iron deficiency anemia.
SFP is an iron-based intravenous therapy that replenishes iron stores and stimulates erythropoiesis in patients with iron deficiency anemia. Used for Iron deficiency anemia in patients with chronic kidney disease, Iron deficiency anemia in patients intolerant to or unresponsive to oral iron.
At a glance
| Generic name | SFP |
|---|---|
| Also known as | Soluble ferric pyrophosphate |
| Sponsor | Rockwell Medical Technologies, Inc. |
| Drug class | Intravenous iron replacement agent |
| Target | Iron (Fe3+) for hemoglobin synthesis and erythropoiesis |
| Modality | Small molecule |
| Therapeutic area | Hematology / Nephrology |
| Phase | FDA-approved |
Mechanism of action
SFP (likely referring to a ferric or iron-based formulation from Rockwell Medical) delivers bioavailable iron intravenously to correct iron deficiency and support red blood cell production. It is designed for patients who cannot tolerate or do not respond adequately to oral iron supplementation, particularly those with chronic kidney disease or other conditions causing iron-deficient anemia.
Approved indications
- Iron deficiency anemia in patients with chronic kidney disease
- Iron deficiency anemia in patients intolerant to or unresponsive to oral iron
Common side effects
- Injection site reactions
- Hypersensitivity reactions
- Headache
- Nausea
- Dizziness
Key clinical trials
- Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD (NA)
- A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia (PHASE2)
- Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program (NA)
- Stress Reactivity and Mother-Infant Cardiovascular Disease Risk (NA)
- Standard Follow-up Program Neuro-oncology Patients (SFP Neuro-Oncology)
- Standard Follow-up Program (SFP) for Breast Cancer Patients
- Standard Follow-up Program (SFP) for Head and Neck Cancer Patients
- Standard Follow-up Program Cervix Cancer (SFP CERVIX)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SFP CI brief — competitive landscape report
- SFP updates RSS · CI watch RSS
- Rockwell Medical Technologies, Inc. portfolio CI